首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >MicroRNA-34a directly targets high-mobility group box 1 and inhibits the cancer cell proliferation migration and invasion in cutaneous squamous cell carcinoma
【2h】

MicroRNA-34a directly targets high-mobility group box 1 and inhibits the cancer cell proliferation migration and invasion in cutaneous squamous cell carcinoma

机译:MicroRNA-34a直接靶向高迁移率的第1盒并抑制皮肤鳞状细胞癌中癌细胞的增殖迁移和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cutaneous squamous cell carcinoma (CSCC) is the second most common type of skin cancer with increasing incidence. In recent years, several microRNAs (miRs) have been demonstrated to serve an oncogenic or tumor suppressive role in CSCC. However, the exact role of miR-34a in CSCC and the underlying regulatory mechanism remain unclear. The present study aimed to investigate the regulatory mechanism of miR-34a in the malignant phenotypes of CSCC cells using MTT assay, wound healing assay and transwell assay. It was observed that miR-34a was significantly downregulated in CSCC tissues and cell lines, and low miR-34a expression was associated with the aggressive progression of CSCC. Restoration of miR-34a significantly suppressed the proliferation, migration and invasion of CSCC SCL-1 cells. High-mobility group box 1 (HMGB1) was then identified as a target gene of miR-34a in SCL-1 cells using bioinformatics prediction. The expression of HMGB1 was significantly upregulated in the CSCC tissues and cell lines. Furthermore, the protein expression of HMGB1 was negatively regulated by miR-34a in SCL-1 cells, while overexpression of HMGB1 impaired the inhibitory effects of miR-34a on SCL-1 cells. These findings suggest that miR-34a represses the malignant phenotypes of CSCC cells, at least partly, via the inhibition of HMGB1. Therefore, miR-34a may be used as a promising therapeutic candidate for CSCC.
机译:皮肤鳞状细胞癌(CSCC)是第二大最常见的皮肤癌,发病率不断上升。近年来,已证明几种microRNA(miR)在CSCC中起致癌或抑癌作用。但是,尚不清楚miR-34a在CSCC中的确切作用和潜在的调控机制。本研究旨在通过MTT法,伤口愈合法和transwell法研究miR-34a在CSCC细胞恶性表型中的调控机制。观察到,在CSCC组织和细胞系中miR-34a显着下调,而低miR-34a表达与CSCC的侵袭性发展相关。 miR-34a的恢复显着抑制CSCC SCL-1细胞的增殖,迁移和侵袭。然后,使用生物信息学预测将高迁移率族框1(HMGB1)鉴定为SCL-1细胞中miR-34a的靶基因。 HMGB1的表达在CSCC组织和细胞系中显着上调。此外,HMGB1的蛋白表达受到SCL-1细胞中miR-34a的负调控,而HMGB1的过表达削弱了miR-34a对SCL-1细胞的抑制作用。这些发现表明,miR-34a至少部分地通过抑制HMGB1而抑制CSCC细胞的恶性表型。因此,miR-34a可用作CSCC的有希望的治疗候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号